Introduction
Small (or short) interfering RNA (siRNA) represents a class of double-stranded RNA molecules, which specifically target a particular mRNA for degradation, thus resulting in gene silencing and knockdown of protein expression (1) (2) (3) . siRNA acts via the RNA interference (RNAi) pathway, where it binds to protein complexes such as Dicer (which dices up siRNA into smaller fragments) and RISC (RNA-induced Silencing Complex), which leads to specific RNA cleavage and degradation (1) (2) (3) . siRNA can act in RNAi-related pathways as an antiviral mechanism, but synthetic siRNAs can also induce RNAi in mammalian cells (4) .
Therefore, siRNA has developed into the most commonly used RNAi tool for the induction of transient, short-term silencing of protein coding genes.
RNAi technologies have been proven to be a valuable tool in the identification and investigation of proteins which are involved in peroxisome biogenesis and function. One illustrative example is the discovery of a role for the dynamin-related protein 1 (DRP1), a large GTPase with mechanochemical properties, in peroxisomal fission (5) (6) (7) (8) . Efficient knockdown of DRP1 in cells of human and rodent origin was achieved with a conserved DRP1 target sequence corresponding to the coding region 783-803 (5, 7) (Fig. 1) .
Remarkably, silencing of DRP1, which localizes to both peroxisomes and mitochondria, resulted in a massive membrane elongation of peroxisomes (and mitochondria) due to a block in organelle division (5, 7) (Fig. 1) . This characteristic peroxisomal morphology was later observed in patient fibroblasts and led to the discovery of DRP1 deficiency, the first member of a new group of disorders with defects in peroxisomal and mitochondrial division (9, 10) .
Although siRNA can induce gene knockdown in a variety of mammalian cell lines, their utility is limited by efficient uptake of synthetic oligonucleotides into the cells. Here, we describe different transfection methods which have been successfully used by us to silence peroxisomal genes in a variety of cell lines, including primary skin fibroblasts, which are usually difficult to transfect.
Materials
All reagents and equipment used to maintain and process living cells need to be sterile, and appropriate aseptic techniques and practices should be applied at all times. 6. siRNA in sterile, RNase/DNase-free water or buffer supplied by manufacturer (50 -100 µM stock).
Mammalian

Controls
Controls are an essential part of every siRNA experiment. It is recommended to add a positive control, a negative control and an untreated control. A well-characterized positive control allows ensuring the experimental set-up (e.g. transfection method, cell line used) is sufficient to achieve effective silencing. We usually include DRP1-specific siRNA as a positive control, which results in a characteristic elongation of peroxisomes (11) (12) (13) (14) (Fig. 1 ).
This morphological alteration can easily be detected by immunofluorescence using peroxisomal marker proteins ( incubator (95% air, 5% CO 2 , 37°C).
3. Refresh the cell culture medium every 2-3 days.
4. Split the cells before they reach 100% confluency (see steps 4 to 14).
Pre-warm 1×PBS, TrypLE™
Express solution, and complete growth medium to 37°C.
6. Remove all medium from the cell culture dish with a Pasteur pipette by vacuum aspiration and wash the cells once with 4 mL of 1×PBS.
7. Add TryplExpress solution to the cells and gently tilt to cover the surface (1 mL/10 cm dish).
8. Incubate the cells for 2-5 min at 37°C.
9. Upon detachment, harvest the cells in complete growth medium (10 mL/10 cm dish).
10. Carefully resuspend the cells by pipetting the cell suspension 2-3 times up and down and further detach remaining cells from the surface of the dish.
11. Transfer the cells to a 15-mL conical tube and take an aliquot of the suspension for cell counting.
12. Pellet the cells by centrifugation (500×g, 3 min at RT).
13. Resuspend the cell pellet in 10 mL of complete growth medium.
14. 2. On the day of transfection, add 4 ml complete growth medium (without antibiotics!) into a 6 cm ∅ culture dish and place in the incubator (see Note 7). For each microporation, a 6 cm ∅ dish is required. For analysis by immunofluorescence, add 4 sterile, clean glass coverslips to the dish prior to adding the medium using sterile tweezers. We routinely use round coverslips (19 mm ∅, 0.13-0.17 mm thickness).
Coverslips are not required for analysis by immunoblotting.
3. Harvest the cells by trypsination, pool them and centrifuge at 500×g for 3 min.
4. Aspirate the supernatant, resuspend the cell pellet in 1×PBS, and centrifuge as above. 7. Add 100 nM siRNA into another sterile 1.5 ml microcentrifuge tube (see Note 11)
8. Gently add 110 µl of cell suspension (in R-buffer) and pipette 1-2 times up and down.
9. Mount a 100 µl Neon tip onto the Neon pipette.
10. Immerse the tip into the cell-siRNA mixture and slowly aspirate 100 µl of the sample.
Avoid generating air bubbles in the tip.
11. Insert the pipette into the E2 buffer-containing tube in the pipette station, and press start on the touch screen.
12. After delivery of the electric pulse, remove the pipette from the pipette station and immediately transfer the cells from the tip to the 6 cm dishes containing the prewarmed growth medium (without antibiotics) (see Note 12).
13. Gently move the dish horizontal and vertical to evenly distribute the cells (see Note 13).
14. Incubate the cells in a humidified CO 2 incubator (95% air, 5% CO 2 , 37°C) for 72
hours to allow efficient silencing (see Note 14). (Figs. 1, 2) .
Using the transfection protocol described, we routinely obtain transfection efficiencies between 70 and 80%. Re-transfection is not required. The mixture is sufficient for transfection of one 6 cm ∅ culture dish.
Transfection of siRNA into mammalian cells using lipofection
3. Meanwhile, wash the cells once with PBS and add 3.5 mL of fresh complete growth medium.
Add the siRNA/Lipofectamine mix dropwise to the cells and incubate in a humidified
CO 2 incubator (95% air, 5% CO 2 , 37°C) for 72 hours to allow efficient silencing.
5. Cells are usually assayed for efficient silencing by indirect immunofluorescence and standard immunoblotting of cell lysates (Figs. 1, 2) . Using the transfection protocol described, we routinely obtain transfection efficiencies between 70 and 80%.
Electroporation (see 3.3) or microporation (15) are alternative transfection methods for HepG2 cells.
Notes
1. Gene silencing in mammalian cultured cells can be achieved by DNA-directed RNAi, in which a DNA vector is used to express short hairpin RNAs, or by directly introducing small, interfering RNA duplexes (siRNA) into target cells. Chemically synthesized small oligonucleotide siRNA duplexes are usually easier to transfect than DNA-based vectors that express siRNA.
2. Synthetic siRNAs are most commonly generated through solid-phase chemical synthesis methods (e.g. 2'-ACE chemistry) providing highly pure, stable, and readily modified siRNAs. Several manufacturers offer support in siRNA design and provide optimized and validated siRNAs and appropriate controls. siRNAs can also be used for knockdown of non-protein coding genes, such as long noncoding RNAs.
3. Follow the biosafety and GMO guidelines of your institution. 5. For sterilisation, glass coverslips are put in a glass petri dish, wrapped in tin foil and drysterilised for 6 h at 180°C.
6. Splitting the cells 24 hours prior to transfection is important to avoid stress due to high cell density. Furthermore, cell counting on the day of transfection is not required anymore and will reduce the handling time of the cells during the transfection procedure.
7. The addition of antibiotics to the growth medium can drastically reduce the viability of freshly transfected cells.
8. A detailed instruction manual of how to use the Neon device can be downloaded from the supplier's website (http://tools.thermofisher.com/content/sfs/manuals/neon_device_man.pdf).
9. Pulse conditions for other cell types need to be optimized. Further information is provided on the supplier's website (https://www.thermofisher.com/be/en/home/life-science/cellculture/transfection/transfection---selection-misc/neon-transfection-system/neonprotocols-cell-line-data.html).
10. We use 10% more R-buffer (110 µl instead of 100 µl) to compensate for pipetting errors and to avoid aspiration of air.
11. Use conical 1.5 ml microcentrifuge tubes instead of round bottom 2 ml microcentrifuge tubes to avoid generation of air bubbles.
12. In case of an electric spark during the electric pulse (due to potential air bubbles), discard the tip with the cells and repeat the microporation using the backup cells.
13. Do not swirl, as this will lead to the accumulation of the cells in the center of the dish.
14. Based on our experience, a change of the growth medium during the 72 hours incubation period is not required.
15. The Neon pipette tips and tubes can be regenerated and reused as described (16) (7) with kind permission of the Company of Biologists). Bars, 10 µm. Immunoblots of cell lysates from controls (scrambled siRNA) and cells transfected with ACBD5 siRNA using anti-ACBD5 and anti-tubulin antibodies. Equal amounts of protein were loaded onto the gel. Tubulin served as a loading control. Bars, 10 µm.
